Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-02

Clinical Trial Update: A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia [Phase 4]

View source ↗

Summary

Phase 4 long-term safety and efficacy study of eszopiclone in elderly patients with primary chronic insomnia; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lunesta (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2009-06-02